NCT02658981 · Interventional trial
Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
Overall registry status Completed
Phase 1
Conditions Glioblastoma, Gliosarcoma, Recurrent Brain Neoplasm
Delaware Valley sites
- Abrams Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory